ID   B16-FLT3L
AC   CVCL_IJ12
SY   B16-Flt3l; B16FLT3
DR   Wikidata; Q54752455
RX   PubMed=10866317;
RX   PubMed=23890195;
CC   Doubling time: 18.4 hours (PubMed=23890195).
CC   Transfected with: MGI; MGI:95560; Flt3l.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
RX   PubMed=10866317;
RA   Mach N., Gillessen S., Wilson S.B., Sheehan C., Mihm M.C. Jr.,
RA   Dranoff G.;
RT   "Differences in dendritic cells stimulated in vivo by tumors
RT   engineered to secrete granulocyte-macrophage colony-stimulating factor
RT   or Flt3-ligand.";
RL   Cancer Res. 60:3239-3246(2000).
//
RX   PubMed=23890195; DOI=10.1186/1475-2867-13-75;
RA   Danciu C., Falamas A., Dehelean C., Soica C., Radeke H.,
RA   Barbu-Tudoran L., Bojin F., Cinta Pinzaru S., Munteanu M.F.;
RT   "A characterization of four B16 murine melanoma cell sublines
RT   molecular fingerprint and proliferation behavior.";
RL   Cancer Cell Int. 13:75.1-75.12(2013).
//